Several hundred lots of formula are affected, officials said. Read more at straitstimes.com. Read more at straitstimes.com.

In a stock market currently obsessed with interest rate cuts and the artificial intelligence (AI) boom, it is easy to ...

Strong efficacy signals showing 33% ORR, 16.6-month PFS, and 27-month OS, improving on the SOC by 2-3X in a ...

FDA officials are advising drug developers to study the long-term effects of using CAR-T in autoimmune conditions out of ...

Through the partnership J&K Ingredients can provide a more coordinated approach with enhanced supply security, accelerated development and commercialization timeliness, and increased agility in ...

Michael Patten, chief strategy officer of Harbour BioMed, a global biotech group with Chinese roots that has a partnership ...

By Sybille de La Hamaide and Alexander Marrow PARIS, Feb 2 (Reuters) - The European food safety body on Monday advised a ...

"Nader Pourhassan lied and schemed to selfishly line his own pockets." ...

Delve into what 2026 has to offer in the biotech industry. The market is showing signs it's picking up and the patent cliff ...

Biotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make ...

Atara Biotherapeutics in Thousand Oaks is seeking approval for a new cancer treatment. It's a life and death matter for ...

A global recall of potentially contaminated infant formula has heaped scrutiny onto the Chinese firm Cabio Biotech, the supplier of the ingredient suspected of being tainted.